9,10-dimethyl-1,2-benzanthracene has been researched along with Ear Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Fu, ZD; Han, R; Wang, KF; Xu, SF | 1 |
Aizu, E; Kato, R; Nakadate, T; Yamamoto, S | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Ear Diseases
Article | Year |
---|---|
[Chemopreventive effect of resveratrol to cancer].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antimutagenic Agents; Croton Oil; Ear Diseases; Edema; Epithelial Cells; Female; Male; Mice; Mice, Inbred ICR; Micronucleus Tests; Mutagenicity Tests; Ornithine Decarboxylase; Papilloma; Resveratrol; Salmonella typhimurium; Skin Neoplasms; Stilbenes | 2004 |
Anti-tumor promoting action of phthalic acid mono-n-butyl ester cupric salt, a biomimetic superoxide dismutase.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Antineoplastic Agents; Benz(a)Anthracenes; Cells, Cultured; Dermatitis, Contact; Dibutyl Phthalate; Ear Diseases; Edema; Enzyme Induction; Epidermal Cells; Epidermis; Female; Mice; Ornithine Decarboxylase; Papilloma; Phthalic Acids; Skin Neoplasms; Superoxide Dismutase; Tetradecanoylphorbol Acetate | 1990 |